[HTML][HTML] Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations: a 2019 update

EJ Smolders, AME Jansen, PGJ Ter Horst… - Clinical …, 2019 - Springer
It has been estimated by the World Health Organization (WHO) that over 71 million people
were infected with the hepatitis C virus (HCV) in 2015. Since then, a number of highly …

Hepatitis C and its impact on renal transplantation

JM Morales, F Fabrizi - Nature Reviews Nephrology, 2015 - nature.com
Infection with hepatitis C virus (HCV) is the major cause of chronic liver disease that occurs
after renal transplantation. Such infection is often acquired during dialysis while patients wait …

Sofosbuvir and simeprevir in hepatitis C genotype 1‐patients with end‐stage renal disease on haemodialysis or GFR< 30 ml/min

HE Nazario, M Ndungu, AA Modi - Liver International, 2016 - Wiley Online Library
Abstract Background & Aims Treating chronic hepatitis C (CHC) in patients with end‐stage
renal disease (ESRD) has suboptimal tolerability and cure rates. Safety and efficacy of …

[HTML][HTML] Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection

MV Lin, ME Sise, M Pavlakis, BM Amundsen, D Chute… - PLoS …, 2016 - journals.plos.org
The prevalence of Hepatitis C Virus (HCV) infection is significantly higher in patients with
end-stage renal disease compared to the general population and poses important clinical …

[HTML][HTML] Impact of protease inhibitor–based anti-retroviral therapy on outcomes for HIV+ kidney transplant recipients

D Sawinski, BA Shelton, S Mehta, RD Reed… - American Journal of …, 2017 - Elsevier
Excellent outcomes have been demonstrated among select HIV-positive kidney transplant
(KT) recipients with well-controlled infection, but to date, no national study has explored …

[HTML][HTML] Superior outcomes in HIV–positive kidney transplant patients compared with HCV–infected or HIV/HCV–coinfected recipients

D Sawinski, KA Forde, K Eddinger, AB Troxel… - Kidney international, 2015 - Elsevier
The prerequisite for an 'undetectable'HIV viral load has restricted access to transplantation
for HIV–infected kidney recipients. However, HCV–infected recipients, owing to the historic …

The changing landscape of HIV-associated kidney disease

NE Diana, S Naicker - Nature Reviews Nephrology, 2024 - nature.com
The HIV epidemic has devastated millions of people globally, with approximately 40 million
deaths since its start. The availability of antiretroviral therapy (ART) has transformed the …

[HTML][HTML] Kidney transplant outcomes in HIV-positive patients: a systematic review and meta-analysis

X Zheng, L Gong, W Xue, S Zeng, Y Xu… - AIDS Research and …, 2019 - Springer
Background Kidney transplantation is now a viable alternative to dialysis in HIV-positive
patients who achieve good immunovirological control with the currently available …

Renal transplantation in advanced chronic kidney disease patients

M Ghanta, B Jim - Medical Clinics, 2016 - medical.theclinics.com
KT is the optimal modality of treatment for patients with ESKD and, if successful, is
associated with improved quality of life, lower medical costs, and improved survival. Better …

[HTML][HTML] HCV-associated nephropathies in the era of direct acting antiviral agents

A Angeletti, C Cantarelli, P Cravedi - Frontiers in Medicine, 2019 - frontiersin.org
Hepatitis C virus (HCV) infection is a systemic disorder that frequently associates with
extrahepatic manifestations, including nephropathies. Cryoglobulinemia is a typical …